[{"NetIncomeLoss_1_Q2_USD":-3804000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":84000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"RestrictedCashCurrent_0_Q2_USD":50000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":2892000.0,"InterestPaidNet_2_Q2_USD":618000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.0168,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-1418000.0,"Depreciation_2_Q2_USD":573000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":162979000.0,"AccumulatedAmortizationDeferredFinanceCosts_0_Q2_USD":130000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":656000.0,"AssetsCurrent_0_Q2_USD":219764000.0,"OperatingLeaseExpense_2_Q2_USD":324000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2_Q2_USD":0.0,"OperatingLeaseExpense_1_Q2_USD":170000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":35273000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":18880000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2_Q2_pure":0.0,"CostOfGoodsAndServicesSold_2_Q2_USD":6193000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":3487000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":25813190.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":45000.0,"InventoryValuationReserves_0_Q2_USD":318000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":628000.0,"AdjustmentsToAdditionalPaidInCapitalWarrantIssued_1_Q2_USD":4486000.0,"IncomeTaxesPaidNet_2_Q2_USD":81000.0,"CommonStockSharesIssued_0_Q2_shares":48360081.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":911000.0,"LongTermDebt_0_Q2_USD":29582000.0,"Liabilities_0_Q2_USD":40484000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":224726000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":194836000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6646000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3628000.0,"DeferredFinanceCostsGross_0_Q2_USD":798000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2896000.0,"EarningsPerShareBasic_2_Q2_USD":0.02,"EarningsPerShareBasic_1_Q2_USD":-0.16,"TemporaryEquityLiquidationPreference_0_Q2_USD":0.0,"PaymentsOfFinancingCosts_2_Q2_USD":12000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":47362292.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":24295900.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3925000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-3201000.0,"AccountsReceivableNetCurrent_0_Q2_USD":15392000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.406,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"CommonStockValue_0_Q2_USD":48000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-255000.0,"IncreaseDecreaseInInventories_2_Q2_USD":1667000.0,"ProceedsFromNotesPayable_2_Q2_USD":10000000.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":2884000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":3317000.0,"Assets_0_Q2_USD":224354000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":668000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_2_Q2_USD":3317000.0,"CapitalizedContractCostNet_0_Q2_USD":149000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":601000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":54170000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":174420000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":179558.0,"ShareBasedCompensation_2_Q2_USD":1000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"CommonStockSharesOutstanding_0_Q2_shares":48360081.0,"EarningsPerShareDiluted_2_Q2_USD":0.01,"EarningsPerShareDiluted_1_Q2_USD":-0.16,"RestrictedCashNoncurrent_0_Q2_USD":338000.0,"AmortizationOfFinancingCosts_2_Q2_USD":113000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1852000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":308000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-3804000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":505000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-1805000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1817000.0,"ProceedsFromWarrantExercises_2_Q2_USD":4000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":15339755.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":24295900.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":4174000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2_Q2_pure":0.406,"AccountsPayableCurrent_0_Q2_USD":2294000.0,"InterestExpense_2_Q2_USD":809000.0,"InterestExpense_1_Q2_USD":463000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":195224000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3866000.0,"CapitalizedContractCostNetNoncurrent_0_Q2_USD":54000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":67000.0,"GrossProfit_2_Q2_USD":46152000.0,"GrossProfit_1_Q2_USD":21905000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_Q2_USD":16300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.0146,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":4176000.0,"NetIncomeLoss_2_Q2_USD":308000.0,"LiabilitiesCurrent_0_Q2_USD":10902000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":171197000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-40904000.0,"CapitalizedContractCostNetCurrent_0_Q2_USD":41000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":707000.0,"DeferredFinanceCostsNet_0_Q2_USD":668000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3391000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":52345000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":25392000.0,"OperatingIncomeLoss_2_Q2_USD":4233000.0,"OperatingIncomeLoss_1_Q2_USD":-603000.0,"AllowanceForDoubtfulAccountsReceivable_0_Q2_USD":146000.0,"InventoryNet_0_Q2_USD":5620000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":164361000.0,"InvestmentIncomeInterest_2_Q2_USD":201000.0,"InvestmentIncomeInterest_1_Q2_USD":146000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":224354000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7223000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":30250000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1418000.0,"StockholdersEquity_0_Q2_USD":183870000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":0.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":0.0,"ProfitLoss_2_Q2_USD":308000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingExpenses_1_Q2_USD":22508000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":6028000.0,"CapitalUnitsAuthorized_0_Q2_shares":310000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":7967000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":505000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingExpenses_2_Q2_USD":41919000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":304000.0,"Ticker":"NARI","CIK":"1531048","name":"INARI MEDICAL, INC.","OfficialName":"Inari Medical Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4973580587.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20200811"}]